Galante Joseph C 4/A
4/A · CUMBERLAND PHARMACEUTICALS INC · Filed Jan 30, 2025
Insider Transaction Report
Form 4/AAmended
Galante Joseph C
Director
Transactions
- Award
Common Stock
2024-03-25$1.71/sh+2,500$4,275→ 60,856 total
Footnotes (1)
- [F1]This amendment is being filed solely to correct an administrative error in reporting the number of Securities Acquired by Reporting Owner on the original Form 4 submitted on March 26, 2024, which were reported as 1,000 shares granted on March 25, 2024, but should have been reported as 2,500 shares. This reflects an increase of 1,500 shares.